Treatment versus conservative management of CIN 2
Julia Palmer
This presentation examines the risks and benefits of selective active surveillance in women with CIN 2 and examines the evidence
Julia Palmer
This presentation examines the risks and benefits of selective active surveillance in women with CIN 2 and examines the evidence